Literature DB >> 10366621

Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

M Buttini1, M Orth, S Bellosta, H Akeefe, R E Pitas, T Wyss-Coray, L Mucke, R W Mahley.   

Abstract

Apolipoprotein (apo) E isoforms are key determinants of susceptibility to Alzheimer's disease. The apoE4 isoform is the major known genetic risk factor for this disease and is also associated with poor outcome after acute head trauma or stroke. To test the hypothesis that apoE3, but not apoE4, protects against age-related and excitotoxin-induced neurodegeneration, we analyzed apoE knockout (Apoe-/-) mice expressing similar levels of human apoE3 or apoE4 in the brain under control of the neuron-specific enolase promoter. Neuronal apoE expression was widespread in the brains of these mice. Kainic acid-challenged wild-type or Apoe-/- mice had a significant loss of synaptophysin-positive presynaptic terminals and microtubule-associated protein 2-positive neuronal dendrites in the neocortex and hippocampus, and a disruption of neurofilament-positive axons in the hippocampus. Expression of apoE3, but not of apoE4, protected against this excitotoxin-induced neuronal damage. ApoE3, but not apoE4, also protected against the age-dependent neurodegeneration seen in Apoe-/- mice. These differences in the effects of apoE isoforms on neuronal integrity may relate to the increased risk of Alzheimer's disease and to the poor outcome after head trauma and stroke associated with apoE4 in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366621      PMCID: PMC6782676     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  70 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain.

Authors:  F Bao; H Arai; S Matsushita; S Higuchi; H Sasaki
Journal:  Neuroreport       Date:  1996-07-29       Impact factor: 1.837

3.  Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.

Authors:  P E Schauwecker; O Steward
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 4.  Excitatory amino acids as a final common pathway for neurologic disorders.

Authors:  S A Lipton; P A Rosenberg
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

5.  Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.

Authors:  T Arendt; C Schindler; M K Brückner; K Eschrich; V Bigl; D Zedlick; L Marcova
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 6.  Human apolipoprotein E: the Alzheimer's disease connection.

Authors:  K H Weisgraber; R W Mahley
Journal:  FASEB J       Date:  1996-11       Impact factor: 5.191

7.  Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study.

Authors:  S H Han; G Einstein; K H Weisgraber; W J Strittmatter; A M Saunders; M Pericak-Vance; A D Roses; D E Schmechel
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

8.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.

Authors:  D A Sanan; K H Weisgraber; S J Russell; R W Mahley; D Huang; A Saunders; D Schmechel; T Wisniewski; B Frangione; A D Roses
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

9.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

Authors:  J K Boyles; R E Pitas; E Wilson; R W Mahley; J M Taylor
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.

Authors:  E M Rockenstein; L McConlogue; H Tan; M Power; E Masliah; L Mucke
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  112 in total

1.  The Apolipoprotein E Epsilon (epsilon) 4 Allele Is Important for Trauma-related Epilepsy.

Authors:  Cynthia L. Harden
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

2.  Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

Authors:  John M Ringman; David Elashoff; Daniel H Geschwind; Brian T Welsh; Karen H Gylys; Cathy Lee; Jeffrey L Cummings; Greg M Cole
Journal:  Arch Neurol       Date:  2012-06

3.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

4.  Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.

Authors:  Joel Kowalewski; Claire Murphy
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

5.  Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice.

Authors:  Jessica A Siegel; Michael J Craytor; Jacob Raber
Journal:  Behav Pharmacol       Date:  2010-10       Impact factor: 2.293

6.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

7.  Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.

Authors:  F Huang; M Buttini; T Wyss-Coray; L McConlogue; T Kodama; R E Pitas; L Mucke
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

8.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration.

Authors:  Jian Luo; Amy H Lin; Eliezer Masliah; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

9.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.

Authors:  Shengjun Chang; Tian ran Ma; R Dennis Miranda; Maureen E Balestra; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

10.  ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.

Authors:  Sonya B Dumanis; Joseph A Tesoriero; Lenard W Babus; Madeline T Nguyen; Justin H Trotter; Mary Jo Ladu; Edwin J Weeber; R Scott Turner; Baoji Xu; G William Rebeck; Hyang-Sook Hoe
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.